This episodes features a conversation with Dr. Romney Humphries and Dr. April Abbott. They join the podcast to talk about a study where Piperacillin-Tazobactam (TZP) was evaluated. Testing results from automated systems were compared to a reference method. How did the systems perform? What are the challenges? What are CLSI breakpoints and FDA breakpoints? What is the MERINO trial? Tune in to find out. Link to article:

https://journals.asm.org/doi/10.1128/jcm.01617-22

Questions? Feedback? Send those to [email protected]

Want to support the podcast? Here's how:

Venmo: https://venmo.com/u/letstalkmicro

Buy me a Ko-fi: https://ko-fi.com/letstalkmicro